Page last updated: 2024-10-23

atenolol and Cirrhosis, Liver

atenolol has been researched along with Cirrhosis, Liver in 11 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Research Excerpts

ExcerptRelevanceReference
"Atenolol was given at a fixed dose of 100 mg/day."2.66Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study. ( Colombo, M; de Franchis, R; Sangiovanni, A; Tommasini, M, 1989)
"She had coronary atherosclerosis, liver cirrhosis and bradycardia-tachycardia syndrome."2.41Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium. ( Hattori, K; Hirakawa, Y; Ichihashi, R; Kei, M; Matsubara, K; Saburi, Y; Sakurai, H; Tsukamoto, H; Yokouchi, K, 2000)
" Hepatic pharmacokinetic modelling was performed with a two-phase physiologically-based organ pharmacokinetic model with the vascular space and dispersion evaluated with the MID technique."1.38Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage. ( Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Weiss, M; Zhang, Q, 2012)
" Studies were undertaken using an in situ-perfused rat liver and multiple indicator dilution, and outflow data were analyzed with a physiologically based organ pharmacokinetic model."1.37Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis. ( Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Thorling, CA; Zhang, Q, 2011)
" Thus, plasma half-life after intravenous dosing of atenolol was 6."1.27Clinical experience with atenolol in patients with chronic liver disease. ( Braun, W; Kirch, W; Mutschler, E; Ohnhaus, EE; Schäfer-Korting, M, 1983)
"The pharmacokinetic properties of propranolol and atenolol were evaluated both in 9 patients with cirrhosis and in 12 healthy subjects."1.27Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients. ( Decourt, S; Flouvat, B; Lebrec, D; Leneveu, A; Rocher, I; Rosier, SP, 1985)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19906 (54.55)18.7374
1990's2 (18.18)18.2507
2000's1 (9.09)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, P2
Robertson, TA2
Thorling, CA1
Zhang, Q2
Fletcher, LM2
Crawford, DH2
Roberts, MS2
Weiss, M1
Mills, PR1
Rae, AP1
Farah, DA1
Russell, RI1
Lorimer, AR1
Carter, DC1
Kirch, W1
Schäfer-Korting, M1
Mutschler, E1
Ohnhaus, EE1
Braun, W1
Sakurai, H1
Kei, M1
Matsubara, K1
Yokouchi, K1
Hattori, K1
Ichihashi, R1
Hirakawa, Y1
Tsukamoto, H1
Saburi, Y1
Ljubicić, N1
Bilić, A1
Avezzano, ES1
Seefe, LB1
Tommasini, M1
de Franchis, R1
Sangiovanni, A1
Colombo, M1
Bonkovsky, HL1
Bonkovsky, ML1
Anderson, PB1
Rothstein, RI1
Erkkinen, JF1
Zoli, M1
Marchesini, G1
Marzocchi, A1
Marrozzini, C1
Dondi, C1
Pisi, E1
Rocher, I1
Decourt, S1
Leneveu, A1
Lebrec, D1
Rosier, SP1
Flouvat, B1

Reviews

2 reviews available for atenolol and Cirrhosis, Liver

ArticleYear
Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium.
    Japanese circulation journal, 2000, Volume: 64, Issue:11

    Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Atrial Fibrillation; Bradycardia; Calcium Channel Block

2000
Prevention of recurrent variceal hemorrhage: to block or not to block?
    The American journal of gastroenterology, 1990, Volume: 85, Issue:5

    Topics: Atenolol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Prop

1990

Trials

5 trials available for atenolol and Cirrhosis, Liver

ArticleYear
Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
    Gut, 1984, Volume: 25, Issue:1

    Topics: Atenolol; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans; Hyperte

1984
The effects of selective and non-selective adrenoceptor blockade on the portal blood flow in patients with liver cirrhosis.
    Scandinavian journal of gastroenterology, 1991, Volume: 26, Issue:7

    Topics: Adult; Analysis of Variance; Atenolol; Blood Flow Velocity; Female; Humans; Labetalol; Liver Cirrhos

1991
Prevention of recurrent variceal hemorrhage: to block or not to block?
    The American journal of gastroenterology, 1990, Volume: 85, Issue:5

    Topics: Atenolol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Prop

1990
Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study.
    Drugs, 1989, Volume: 37 Suppl 2

    Topics: Adrenergic beta-Antagonists; Atenolol; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Human

1989
Atenolol for prevention of rebleeding from esophageal varices in hepatic cirrhosis: results of a controlled, randomized pilot study.
    The American journal of gastroenterology, 1989, Volume: 84, Issue:6

    Topics: Atenolol; Clinical Trials as Topic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Liv

1989

Other Studies

5 other studies available for atenolol and Cirrhosis, Liver

ArticleYear
Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cations; Cytochrome P-450

2011
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.
    Pharmaceutical research, 2012, Volume: 29, Issue:6

    Topics: Adrenergic Antagonists; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti

2012
Clinical experience with atenolol in patients with chronic liver disease.
    Journal of clinical pharmacology, 1983, Volume: 23, Issue:4

    Topics: Administration, Oral; Adult; Atenolol; Chronic Disease; Female; Humans; Injections, Intravenous; Kid

1983
Portal pressure changes induced by medical treatment: US detection.
    Radiology, 1985, Volume: 155, Issue:3

    Topics: Adult; Atenolol; Blood Pressure; Esophageal and Gastric Varices; Female; Hepatic Veins; Humans; Live

1985
Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients.
    International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:8

    Topics: Adult; Atenolol; Cardiac Output; Depression, Chemical; Female; Half-Life; Hemodynamics; Humans; Kine

1985
chemdatabank.com